S3 Connected Health design and develop ‘Digital Therapy Management Solutions’, ‘Digitally Enhanced Patient Support Services’ and ‘Digital Therapeutics’ that increase patient engagement, enable patient-self management and improve healthcare outcomes.
We start with understanding patient and clinician needs, to co-create solutions that integrate behavioral science. Our cloud-based platform delivers personalized support and interventions for each patient’s condition and circumstance.
With over 16 years’ experience and having delivered award-winning solutions across 20 therapy areas in over 49 countries, our multi-disciplinary team create solutions which are scalable, secure and regulatory compliant.
IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services focused on helping healthcare clients find better solutions for patients. Formed through the merger of IMS Health and Quintiles, IQVIA applies Human Data Science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes.
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
JAZZ Venture Partners invests in companies that extend the boundaries of human performance — improving how we live, learn, work, play, and experience the world.
We seek breakthroughs at the intersection of digital technology and neuroscience that are influencing the human experience, such as augmented reality, artificial intelligence, immersive gaming, and closed-loop human-computer systems.
Our portfolio companies are unlocking human potential in health, mind-body wellness, accelerated learning and training, sports, entertainment, and the enterprise.
MedCity is an independent, not-for-profit cluster organisation that works to promote and grow life sciences investment, entrepreneurship and industry across London and the greater south east of England.
Supported by the Mayor of London, the London Academic Health Science Centres, research institutes and life sciences organisations across the region, MedCity acts as a front door to the sector. From drug discovery to devices, diagnostics and digital health, MedCity works with industry, researchers and investors looking for partners, investment, infrastructure and expertise.
We aim to facilitate greater connectivity across industry, academia and the health service.
Find out more at MedCityHQ.com or follow us on Twitter @MedCityHQ
In 2011, StartUp Health introduced a new model for transforming health by organizing, supporting, and investing in a global army of entrepreneurs called Health Transformers. With the world’s largest digital health portfolio (250+ companies spanning six continents, 20 countries and 70+ cities), StartUp Health is mobilizing this rapidly growing army along with the world’s ‘batteries included’ leaders, innovators, and investors to achieve 10 Health Moonshots, with a 25-year mission to improve the health and wellbeing of everyone in the world.